Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004.

Cree M, Tonita J, Turner D, Nugent Z, Alvi R, Barss R, King C, Winget M.

Clin Colorectal Cancer. 2009 Jul;8(3):141-5. doi: 10.3816/CCC.2009.n.023.

PMID:
19632928
2.

Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada.

Eldin NS, Yasui Y, Scarfe A, Winget M.

Clin Oncol (R Coll Radiol). 2012 Feb;24(1):e9-17. doi: 10.1016/j.clon.2011.07.005. Epub 2011 Jul 30.

PMID:
21802914
3.

Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer.

Cronin DP, Harlan LC, Potosky AL, Clegg LX, Stevens JL, Mooney MM.

Am J Gastroenterol. 2006 Oct;101(10):2308-18.

PMID:
17032196
4.

Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces.

Wirtzfeld DA, Mikula L, Gryfe R, Ravani P, Dicks EL, Parfrey P, Gallinger S, Pollett WG.

Can J Surg. 2009 Apr;52(2):92-7.

5.

Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment.

Winget M, Hossain S, Yasui Y, Scarfe A.

Cancer. 2010 Oct 15;116(20):4849-56. doi: 10.1002/cncr.25250.

6.

Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration.

Landrum MB, Keating NL, Lamont EB, Bozeman SR, McNeil BJ.

Cancer. 2012 Jul 1;118(13):3345-55. doi: 10.1002/cncr.26628. Epub 2011 Nov 9.

7.

Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada.

Lima IS, Yasui Y, Scarfe A, Winget M.

Cancer. 2011 Aug 15;117(16):3833-40. doi: 10.1002/cncr.25954. Epub 2011 Feb 11.

8.

Adjuvant systemic therapies in patients with colorectal cancer: an audit on clinical practice in Italy.

Drug Utilization Review Team in Oncology.

Tumori. 2005 Nov-Dec;91(6):472-6.

PMID:
16457144
9.

Adjuvant therapy for colon and rectal cancer.

Ratkin GA.

Am Fam Physician. 1997 May 15;55(7):2487-92, 2495-6.

PMID:
9166147
10.

Residual treatment disparities after oncology referral for rectal cancer.

Morris AM, Billingsley KG, Hayanga AJ, Matthews B, Baldwin LM, Birkmeyer JD.

J Natl Cancer Inst. 2008 May 21;100(10):738-44. doi: 10.1093/jnci/djn145. Epub 2008 May 13.

11.

[Adjuvant and palliative chemotherapy of colorectal cancer in Germany outside controlled trials].

Lamberti C, Lundin S, Bogdanow M, Gorschl├╝ter M, Schmidt-Wolf IG, Sauerbruch T.

Dtsch Med Wochenschr. 2006 Mar 10;131(10):485-90. German.

PMID:
16511737
12.

Receipt of recommended therapy by patients with advanced colorectal cancer.

Abraham NS, Gossey JT, Davila JA, Al-Oudat S, Kramer JK.

Am J Gastroenterol. 2006 Jun;101(6):1320-8.

PMID:
16771956
13.

[Practical neoadjuvant and adjuvant therapies for rectal cancer. How many patients are actually recruited in multimodality therapy concepts? An analysis of the Tumour Centre Schwerin].

Sauer J, Sobolewski K, Dommisch K.

Zentralbl Chir. 2009 Sep;134(5):450-4. doi: 10.1055/s-0028-1098930. Epub 2009 Sep 15. German.

PMID:
19757345
14.
15.

Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study.

Ahmed S, Ahmad I, Zhu T, Arnold FP, Faiz Anan G, Sami A, Yadav SK, Alvi R, Haider K.

Dis Colon Rectum. 2010 Oct;53(10):1432-8. doi: 10.1007/DCR.0b013e3181e78815.

PMID:
20847626
16.

Utilization of oncology services and receipt of treatment: a comparison between patients with breast, colon, rectal, or lung cancer.

Li X, Butts C, Fenton D, King K, Scarfe A, Winget M.

Ann Oncol. 2011 Aug;22(8):1902-9. doi: 10.1093/annonc/mdq692. Epub 2011 Jan 28.

17.

Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare.

Schrag D, Gelfand SE, Bach PB, Guillem J, Minsky BD, Begg CB.

J Clin Oncol. 2001 Sep 1;19(17):3712-8.

PMID:
11533092
18.

Reasons physicians do not recommend and patients refuse adjuvant chemotherapy for stage III colon cancer: a population based chart review.

El Shayeb M, Scarfe A, Yasui Y, Winget M.

BMC Res Notes. 2012 Jun 7;5:269. doi: 10.1186/1756-0500-5-269.

19.

Adherence to clinical practice guidelines for adjuvant chemotherapy for colorectal cancer in a Canadian province: a population-based analysis.

Rayson D, Urquhart R, Cox M, Grunfeld E, Porter G.

J Oncol Pract. 2012 Jul;8(4):253-9. doi: 10.1200/JOP.2012.000578.

20.

Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort.

Ayanian JZ, Zaslavsky AM, Fuchs CS, Guadagnoli E, Creech CM, Cress RD, O'Connor LC, West DW, Allen ME, Wolf RE, Wright WE.

J Clin Oncol. 2003 Apr 1;21(7):1293-300.

PMID:
12663717
Items per page

Supplemental Content

Write to the Help Desk